CNS vs RILYZ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

CNS

69.5
AI Score
VS
CNS Wins

RILYZ

63.3
AI Score

Investment Advisor Scores

CNS

70score
Recommendation
BUY

RILYZ

63score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CNS RILYZ Winner
Revenue 94.41M 591.18M RILYZ
Net Income 29.96M 233.82M RILYZ
Net Margin 31.7% 39.6% RILYZ
Operating Income 36.29M 191.12M RILYZ
ROE 9.9% 164.5% RILYZ
ROA 6.7% 11.9% RILYZ
Total Assets 450.12M 1.97B RILYZ
Cash 193.73M 154.11M CNS

Relative Price Performance (Last 90 Days)

CNS 1M: -4.9% · 3M: -7.5% RILYZ 1M: -6.0% · 3M: +6.9%

Current Technical Phase

CNS

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 38

RSI (14): 38.1 · Price: $73.46

RILYZ

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.3 · Price: $19.76

Fundamentals Snapshot

Metric CNS RILYZ
Market Cap — —
Forward P/E 18.4 0.0
Trailing P/E 22.4 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.5% —
Operating Margin 0.3% 0.0%
EPS 3.26 0.00
Dividend Yield 0.04% —

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.